Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability

Apoptosis

Volumn 16, Issue 2, 2011, Pages 174-183

  Juan, Hsien Chia ^a   Tsai, Hsin Ting ^a   Chang, Po Hao ^a   Huang, Chi Ying F ^a   Hu, Cheng Po ^b   Wong, Fen Hwa ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

5 fluorouracil (5 Fu); Apoptosis; Esophageal carcinoma; Insulin like growth factor 1 (IGF 1); Survivin

Indexed keywords

CASEIN KINASE II; FLUOROURACIL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT SOMATOMEDIN C; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CARCINOMA CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ESOPHAGUS CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; SENSITIZATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; CASEIN KINASE II; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 79951579534     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-010-0555-z     Document Type: Article

References (40)

1. PC Enzinger DH Ilson DP Kelsen 1999 Chemotherapy in esophageal cancer Semin Oncol 26 12 20 1:CAS:528:DyaK1MXnslSjt7s%3D 10566606 (Pubitemid 29529532)
2. K Sumpter C Harper-Wynne D Cunningham, et al. 2005 Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF Br J Cancer 92 1976 1983 1:CAS:528:DC%2BD2MXks1GntLw%3D 10.1038/sj.bjc.6602572 15928658 (Pubitemid 40897418)
3. Y Akutsu H Matsubara K Shuto, et al. 2009 Clinical and pathologic evaluation of the effectiveness of neoadjuvant chemoradiation therapy in advanced esophageal cancer patients World J Surg 33 1002 1009 10.1007/s00268-008-9899-8 19247705
4. DB Longley DP Harkin PG Johnston 2003 5-fluorouracil: mechanisms of action and clinical strategies Nat Rev Cancer 3 330 338 1:CAS:528: DC%2BD3sXjtlals70%3D 10.1038/nrc1074 12724731 (Pubitemid 37328853)
5. P Graidist A Phongdara K Fujise 2004 Antiapoptotic protein partners fortilin and MCL1 independently protect cells from 5-fluorouracil-induced cytotoxicity J Biol Chem 279 40868 40875 1:CAS:528:DC%2BD2cXnslWntbk%3D 10.1074/jbc.M401454200 15262975 (Pubitemid 39287685)
6. H Zhu W Guo L Zhang, et al. 2005 Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells Mol Cancer Ther 4 451 456 1:CAS:528:DC%2BD2MXit1Knsrg%3D 10.1158/1535-7163.MCT-04- 0330 15767554 (Pubitemid 40767123)
7. S Zhang F Ding A Luo, et al. 2007 XIAP is highly expressed in esophageal cancer and its downregulation by RNAi sensitizes esophageal carcinoma cell lines to chemotherapeutics Cancer Biol Ther 6 973 980 1:CAS:528:DC%2BD2sXht1yktrbL 17611394
8. G Ambrosini C Adida G Sirugo DC Altieri 1998 Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting J Biol Chem 273 11177 11182 1:CAS:528:DyaK1cXjtFGrsr4%3D 10.1074/jbc.273.18.11177 9556606 (Pubitemid 28204967)
9. F Li G Ambrosini EY Chu, et al. 1998 Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 580 584 1:CAS:528:DyaK1cXotVWns70%3D 10.1038/25141 9859993 (Pubitemid 28563719)
10. DC Altieri 2003 Survivin, versatile modulation of cell division and apoptosis in cancer Oncogene 22 8581 8589 1:CAS:528:DC%2BD3sXptFOmtbY%3D 10.1038/sj.onc.1207113 14634620 (Pubitemid 38019195)
11. A Rosato M Pivetta A Parenti, et al. 2006 Survivin in esophageal cancer: an accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma Int J Cancer 119 1717 1722 1:CAS:528:DC%2BD28Xos1Khurk%3D 10.1002/ijc.21923 16671090 (Pubitemid 44258782)
12. J Kato Y Kuwabara M Mitani, et al. 2001 Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy Int J Cancer 95 92 95 1:CAS:528:DC%2BD3MXitV2ks7w%3D 10.1002/1097-0215(20010320) 95:2<92::AID-IJC1016>3.0.CO;2-9 11241318 (Pubitemid 32187079)
13. QL Deveraux E Leo HR Stennicke K Welsh GS Salvesen JC Reed 1999 Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases EMBO J 18 5242 5251 1:CAS:528:DyaK1MXntFKqs70%3D 10.1093/emboj/18.19.5242 10508158 (Pubitemid 29465575)
14. H Marusawa S Matsuzawa K Welsh, et al. 2003 HBXIP functions as a cofactor of survivin in apoptosis suppression EMBO J 22 2729 2740 1:CAS:528: DC%2BD3sXkt1Wrt7g%3D 10.1093/emboj/cdg263 12773388 (Pubitemid 36712369)
15. T Dohi K Okada F Xia, et al. 2004 An IAP-IAP complex inhibits apoptosis J Biol Chem 279 34087 34090 1:CAS:528:DC%2BD2cXmvFensbY%3D 10.1074/jbc.C400236200 15218035 (Pubitemid 39318028)
16. Z Song X Yao M Wu 2003 Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis J Biol Chem 278 23130 23140 1:CAS:528: DC%2BD3sXksF2hs74%3D 10.1074/jbc.M300957200 12660240 (Pubitemid 36830379)
17. G Ceballos-Cancino M Espinosa V Maldonado J Melendez-Zajgla 2007 Regulation of mitochondrial Smac/DIABLO-selective release by survivin Oncogene 26 7569 7575 1:CAS:528:DC%2BD2sXhtlKmurvN 10.1038/sj.onc.1210560 17546047 (Pubitemid 350207708)
18. M Zhang DE Latham MA Delaney A Chakravarti 2005 Survivin mediates resistance to antiandrogen therapy in prostate cancer Oncogene 24 2474 2482 1:CAS:528:DC%2BD2MXivFOhu70%3D 10.1038/sj.onc.1208490 15735703 (Pubitemid 40593038)
19. A Imsumran Y Adachi H Yamamoto, et al. 2006 Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma Carcinogenesis 28 947 956 10.1093/carcin/bgl247 17183068
20. YC Liu CM Leu FH Wong, et al. 2002 Autocrine stimulation by insulin-like growth factor I is involved in the growth, tumorigenicity and chemoresistance of human esophageal carcinoma cells J Biomed Sci 9 665 674 1:CAS:528: DC%2BD3sXptVOjug%3D%3D 10.1007/BF02254995 12432233
21. G Cozza M Mazzorana E Papinutto, et al. 2009 Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2 Biochem J 421 387 395 1:CAS:528:DC%2BD1MXosV2hurk%3D 10.1042/BJ20090069 19432557
22. S Sarno H Reddy F Meggio, et al. 2001 Selectivity of 4, 5, 6, 7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2') FEBS Lett 496 44 48 1:CAS:528:DC%2BD3MXjtlCit7o%3D 10.1016/S0014-5793(01)02404-8 11343704 (Pubitemid 32436419)
23. DC Altieri 2008 Survivin, cancer networks and pathway-directed drug discovery Nat Rev Cancer 8 61 70 1:CAS:528:DC%2BD2sXhsVKku73M 10.1038/nrc2293 18075512
24. V Vaira CW Lee HL Goel S Bosari LR Languino DC Altieri 2006 Regulation of survivin expression by IGF-1/mTOR signaling Oncogene 26 2678 2684 10.1038/sj.onc.1210094 17072337
25. JC Tapia VA Torres DA Rodriguez L Leyton AF Quest 2006 Casein kinase 2 (CK2) increases survivin expression via enhanced {beta}-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription Proc Natl Acad Sci USA 103 15079 15084 1:CAS:528:DC%2BD28XhtFais7rM 10.1073/pnas.0606845103 17005722 (Pubitemid 44583167)
26. DS O'Connor D Grossman J Plescia, et al. 2000 Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin Proc Natl Acad Sci USA 97 13103 13107 10.1073/pnas.240390697 11069302
27. T Dohi F Xia DC Altieri 2007 Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection Mol Cell 27 17 28 1:CAS:528: DC%2BD2sXot1els7w%3D 10.1016/j.molcel.2007.06.004 17612487 (Pubitemid 46991388)
28. DC Altieri PC Marchisio 1999 Survivin apoptosis: an interloper between cell death and cell proliferation in cancer Lab Invest 79 1327 1333 1:STN:280:DC%2BD3c%2FktFKhsA%3D%3D 10576203
29. BH Kang DC Altieri 2006 Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein (AIP) J Biol Chem 281 24721 24727 1:CAS:528:DC%2BD28Xot1eqtLs%3D 10.1074/jbc.M603175200 16807248 (Pubitemid 44274246)
30. P Fortugno E Beltrami J Plescia, et al. 2003 Regulation of survivin function by Hsp90 Proc Natl Acad Sci USA 100 13791 13796 1:CAS:528: DC%2BD3sXpsFGisrc%3D 10.1073/pnas.2434345100 14614132 (Pubitemid 37499145)
31. JC Ghosh T Dohi BH Kang DC Altieri 2008 Hsp60 regulation of tumor cell apoptosis J Biol Chem 283 5188 5194 1:CAS:528:DC%2BD1cXhvFektrg%3D 10.1074/jbc.M705904200 18086682
32. X Ling RJ Bernacki MG Brattain F Li 2004 Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest J Biol Chem 279 15196 15203 1:CAS:528:DC%2BD2cXivVKgs7g%3D 10.1074/jbc.M310947200 14722122 (Pubitemid 38618915)
33. NR Wall DS O'Connor J Plescia Y Pommier DC Altieri 2003 Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis Cancer Res 63 230 235 1:CAS:528:DC%2BD3sXjvFKnsQ%3D%3D 12517802 (Pubitemid 36070444)
34. O Brenes F Arce O Gatjens-Boniche C Diaz 2007 Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: possible mechanisms of cell resistance Biomed Pharmacother 61 347 355 1:CAS:528:DC%2BD2sXos1Sjs74%3D 10.1016/j.biopha.2007.02.007 17399942 (Pubitemid 47187634)
35. T Iwasa I Okamoto M Suzuki, et al. 2008 Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines Clin Cancer Res 14 6496 6504 1:CAS:528:DC%2BD1cXht1KgtbnO 10.1158/1078-0432.CCR-08-0468 18927289
36. BD Cohen DA Baker C Soderstrom, et al. 2005 Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751, 871 Clin Cancer Res 11 2063 2073 1:CAS:528:DC%2BD2MXitVKrtr0%3D 10.1158/1078-0432.CCR-04-1070 15756033 (Pubitemid 40471873)
37. CP Hu HG Hsieh KY Chien, et al. 1984 Biologic properties of three newly established human esophageal carcinoma cell lines J Natl Cancer Inst 72 577 583 1:STN:280:DyaL2c7jvFKltw%3D%3D 6583441
38. FH Wong CP Hu JH Chiu, et al. 1994 Expression of multiple oncogenes in human esophageal carcinomas Cancer Invest 12 121 131 1:CAS:528: DyaK2cXksl2kur8%3D 10.3109/07357909409024867 8131089
39. NJ Waterhouse JC Goldstein AO von M Schuler DD Newmeyer DR Green 2001 Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process J Cell Biol 153 319 328 1:CAS:528:DC%2BD3MXivFOiurc%3D 10.1083/jcb.153.2.319 11309413 (Pubitemid 34280218)
40. PG Ekert J Silke CJ Hawkins AM Verhagen DL Vaux 2001 DIABLO promotes apoptosis by removing MIHA/XIAP from processed caspase 9 J Cell Biol 152 483 490 1:CAS:528:DC%2BD3MXhtVGqtLg%3D 10.1083/jcb.152.3.483 11157976 (Pubitemid 34280232)